Cargando…

Lipidomics Analysis of Free Fatty Acids in Human Plasma of Healthy and Diabetic Subjects by Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS)

Targeted analytical methods for the determination of free fatty acids (FFAs) in human plasma are of high interest because they may help in identifying biomarkers for diseases and in monitoring the progress of a disease. The determination of FFAs is of particular importance in the case of metabolic d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kokotou, Maroula G., Mantzourani, Christiana, Batsika, Charikleia S., Mountanea, Olga G., Eleftheriadou, Ioanna, Kosta, Ourania, Tentolouris, Nikolaos, Kokotos, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138513/
https://www.ncbi.nlm.nih.gov/pubmed/35625925
http://dx.doi.org/10.3390/biomedicines10051189
_version_ 1784714640834428928
author Kokotou, Maroula G.
Mantzourani, Christiana
Batsika, Charikleia S.
Mountanea, Olga G.
Eleftheriadou, Ioanna
Kosta, Ourania
Tentolouris, Nikolaos
Kokotos, George
author_facet Kokotou, Maroula G.
Mantzourani, Christiana
Batsika, Charikleia S.
Mountanea, Olga G.
Eleftheriadou, Ioanna
Kosta, Ourania
Tentolouris, Nikolaos
Kokotos, George
author_sort Kokotou, Maroula G.
collection PubMed
description Targeted analytical methods for the determination of free fatty acids (FFAs) in human plasma are of high interest because they may help in identifying biomarkers for diseases and in monitoring the progress of a disease. The determination of FFAs is of particular importance in the case of metabolic disorders because FFAs have been associated with diabetes. We present a liquid chromatography-high resolution mass spectrometry (LC-HRMS) method, which allows the simultaneous determination of 74 FFAs in human plasma. The method is fast (10-min run) and straightforward, avoiding any derivatization step and tedious sample preparation. A total of 35 standard saturated and unsaturated FFAs, as well as 39 oxygenated (either hydroxy or oxo) saturated FFAs, were simultaneously detected and quantified in plasma samples from 29 subjects with type 2 diabetes mellitus (T2D), 14 with type 1 diabetes mellitus (T1D), and 28 healthy subjects. Alterations in the levels of medium-chain FFAs (C6:0 to C10:0) were observed between the control group and T2D and T1D patients.
format Online
Article
Text
id pubmed-9138513
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91385132022-05-28 Lipidomics Analysis of Free Fatty Acids in Human Plasma of Healthy and Diabetic Subjects by Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS) Kokotou, Maroula G. Mantzourani, Christiana Batsika, Charikleia S. Mountanea, Olga G. Eleftheriadou, Ioanna Kosta, Ourania Tentolouris, Nikolaos Kokotos, George Biomedicines Article Targeted analytical methods for the determination of free fatty acids (FFAs) in human plasma are of high interest because they may help in identifying biomarkers for diseases and in monitoring the progress of a disease. The determination of FFAs is of particular importance in the case of metabolic disorders because FFAs have been associated with diabetes. We present a liquid chromatography-high resolution mass spectrometry (LC-HRMS) method, which allows the simultaneous determination of 74 FFAs in human plasma. The method is fast (10-min run) and straightforward, avoiding any derivatization step and tedious sample preparation. A total of 35 standard saturated and unsaturated FFAs, as well as 39 oxygenated (either hydroxy or oxo) saturated FFAs, were simultaneously detected and quantified in plasma samples from 29 subjects with type 2 diabetes mellitus (T2D), 14 with type 1 diabetes mellitus (T1D), and 28 healthy subjects. Alterations in the levels of medium-chain FFAs (C6:0 to C10:0) were observed between the control group and T2D and T1D patients. MDPI 2022-05-20 /pmc/articles/PMC9138513/ /pubmed/35625925 http://dx.doi.org/10.3390/biomedicines10051189 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kokotou, Maroula G.
Mantzourani, Christiana
Batsika, Charikleia S.
Mountanea, Olga G.
Eleftheriadou, Ioanna
Kosta, Ourania
Tentolouris, Nikolaos
Kokotos, George
Lipidomics Analysis of Free Fatty Acids in Human Plasma of Healthy and Diabetic Subjects by Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS)
title Lipidomics Analysis of Free Fatty Acids in Human Plasma of Healthy and Diabetic Subjects by Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS)
title_full Lipidomics Analysis of Free Fatty Acids in Human Plasma of Healthy and Diabetic Subjects by Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS)
title_fullStr Lipidomics Analysis of Free Fatty Acids in Human Plasma of Healthy and Diabetic Subjects by Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS)
title_full_unstemmed Lipidomics Analysis of Free Fatty Acids in Human Plasma of Healthy and Diabetic Subjects by Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS)
title_short Lipidomics Analysis of Free Fatty Acids in Human Plasma of Healthy and Diabetic Subjects by Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS)
title_sort lipidomics analysis of free fatty acids in human plasma of healthy and diabetic subjects by liquid chromatography-high resolution mass spectrometry (lc-hrms)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138513/
https://www.ncbi.nlm.nih.gov/pubmed/35625925
http://dx.doi.org/10.3390/biomedicines10051189
work_keys_str_mv AT kokotoumaroulag lipidomicsanalysisoffreefattyacidsinhumanplasmaofhealthyanddiabeticsubjectsbyliquidchromatographyhighresolutionmassspectrometrylchrms
AT mantzouranichristiana lipidomicsanalysisoffreefattyacidsinhumanplasmaofhealthyanddiabeticsubjectsbyliquidchromatographyhighresolutionmassspectrometrylchrms
AT batsikacharikleias lipidomicsanalysisoffreefattyacidsinhumanplasmaofhealthyanddiabeticsubjectsbyliquidchromatographyhighresolutionmassspectrometrylchrms
AT mountaneaolgag lipidomicsanalysisoffreefattyacidsinhumanplasmaofhealthyanddiabeticsubjectsbyliquidchromatographyhighresolutionmassspectrometrylchrms
AT eleftheriadouioanna lipidomicsanalysisoffreefattyacidsinhumanplasmaofhealthyanddiabeticsubjectsbyliquidchromatographyhighresolutionmassspectrometrylchrms
AT kostaourania lipidomicsanalysisoffreefattyacidsinhumanplasmaofhealthyanddiabeticsubjectsbyliquidchromatographyhighresolutionmassspectrometrylchrms
AT tentolourisnikolaos lipidomicsanalysisoffreefattyacidsinhumanplasmaofhealthyanddiabeticsubjectsbyliquidchromatographyhighresolutionmassspectrometrylchrms
AT kokotosgeorge lipidomicsanalysisoffreefattyacidsinhumanplasmaofhealthyanddiabeticsubjectsbyliquidchromatographyhighresolutionmassspectrometrylchrms